401 related articles for article (PubMed ID: 19068102)
1. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.
Valera FC; Queiroz R; Scrideli C; Tone LG; Anselmo-Lima WT
Clin Exp Allergy; 2009 Jan; 39(1):81-8. PubMed ID: 19068102
[TBL] [Abstract][Full Text] [Related]
2. Expression of transcription factors NF-kappaB and AP-1 in nasal polyposis.
Valera FC; Queiroz R; Scrideli C; Tone LG; Anselmo-Lima WT
Clin Exp Allergy; 2008 Apr; 38(4):579-85. PubMed ID: 18352974
[TBL] [Abstract][Full Text] [Related]
3. Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids.
Pujols L; Alobid I; Benítez P; Martínez-Antón A; Roca-Ferrer J; Fokkens WJ; Mullol J; Picado C
Allergy; 2008 Oct; 63(10):1377-86. PubMed ID: 18671773
[TBL] [Abstract][Full Text] [Related]
4. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
Benson M; Strannegård IL; Strannegård O; Wennergren G
J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
[TBL] [Abstract][Full Text] [Related]
5. GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.
Hamilos DL; Leung DY; Muro S; Kahn AM; Hamilos SS; Thawley SE; Hamid QA
J Allergy Clin Immunol; 2001 Jul; 108(1):59-68. PubMed ID: 11447383
[TBL] [Abstract][Full Text] [Related]
6. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium.
Mullol J; López E; Roca-Ferrer J; Xaubet A; Pujols L; Fernàndez-Morata JC; Fabra JM; Picado C
Clin Exp Allergy; 1997 Dec; 27(12):1432-41. PubMed ID: 9433939
[TBL] [Abstract][Full Text] [Related]
7. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.
Ebbens FA; Georgalas C; Luiten S; van Drunen CM; Badia L; Scadding GK; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Lund VJ; Fokkens WJ
Laryngoscope; 2009 Feb; 119(2):401-8. PubMed ID: 19160404
[TBL] [Abstract][Full Text] [Related]
8. Changes of glucocorticoid receptor expression in the nasal polyps of patients with chronic sinusitis following treatment with glucocorticoid.
Watanabe S; Suzaki H
In Vivo; 2008; 22(1):37-42. PubMed ID: 18396779
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of efficacy of topical corticosteroid for the clinical treatment of nasal polyposis: searching for clinical events that may predict response to treatment.
Valera FC; Anselmo-Lima WT
Rhinology; 2007 Mar; 45(1):59-62. PubMed ID: 17432072
[TBL] [Abstract][Full Text] [Related]
10. Nuclear translocation of the glucocorticoid receptor in fibroblasts of asthmatic patients with nasal polyposis insensitive to glucocorticoid treatment.
Embid C; Fernández-Bertolín L; Pujols L; Alobid I; Mullol J; Picado C
Arch Bronconeumol; 2011 Mar; 47(3):115-21. PubMed ID: 21288619
[TBL] [Abstract][Full Text] [Related]
11. A correlative study of NF-kappaB activity and cytokines expression in human chronic nasal sinusitis.
Xu R; Xu G; Shi J; Wen W
J Laryngol Otol; 2007 Jul; 121(7):644-9. PubMed ID: 17040605
[TBL] [Abstract][Full Text] [Related]
12. Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels.
af Klint E; Grundtman C; Engström M; Catrina AI; Makrygiannakis D; Klareskog L; Andersson U; Ulfgren AK
Arthritis Rheum; 2005 Dec; 52(12):3880-9. PubMed ID: 16320336
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by glucocorticoids of the interleukin-1beta-enhanced expression of the mast cell growth factor SCF.
Da Silva CA; Kassel O; Mathieu E; Massard G; Gasser B; Frossard N
Br J Pharmacol; 2002 Apr; 135(7):1634-40. PubMed ID: 11934803
[TBL] [Abstract][Full Text] [Related]
14. Oral steroids enhance epithelial repair in nasal polyposis via upregulation of the AP-1 gene network.
Li CW; Cheung W; Lin ZB; Li TY; Lim JT; Wang DY
Thorax; 2009 Apr; 64(4):306-12. PubMed ID: 19158123
[TBL] [Abstract][Full Text] [Related]
15. Effect of budesonide and nedocromil sodium on IL-6 and IL-8 release from human nasal mucosa and polyp epithelial cells.
Xaubet A; Mullol J; Roca-Ferrer J; Pujols L; Fuentes M; Pérez M; Fabra JM; Picado C
Respir Med; 2001 May; 95(5):408-14. PubMed ID: 11392584
[TBL] [Abstract][Full Text] [Related]
16. Clara cell 10-kDa protein expression in chronic rhinosinusitis and its cytokine-driven regulation in sinonasal mucosa.
Liu Z; Lu X; Zhang XH; Bochner BS; Long XB; Zhang F; Wang H; Cui YH
Allergy; 2009 Jan; 64(1):149-57. PubMed ID: 19076932
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid therapy increases membrane-tethered while decreases secreted mucin expression in nasal polyps.
Martínez-Antón A; de Bolós C; Alobid I; Benítez P; Roca-Ferrer J; Picado C; Mullol J
Allergy; 2008 Oct; 63(10):1368-76. PubMed ID: 18547287
[TBL] [Abstract][Full Text] [Related]
18. Topical glucocorticoids downregulate COX-1 positive cells in nasal polyps.
Ebbens FA; Maldonado M; de Groot EJ; Alobid I; van Drunen CM; Picado C; Fokkens WJ; Mullol J
Allergy; 2009 Jan; 64(1):96-103. PubMed ID: 19132974
[TBL] [Abstract][Full Text] [Related]
19. Impact of mitomycin C on the mRNA expression signatures of immunological biomarkers in eosinophilic nasal polyposis.
de Castro MC; Rocha-Silva F; Gomes LI; Zauli DA; de Moraes Mourão M; de Castro MM; Guimarães RE; Teixeira-Carvalho A; Martins-Filho OA
Am J Rhinol Allergy; 2013 Jan; 27(1):e32-41. PubMed ID: 23406597
[TBL] [Abstract][Full Text] [Related]
20. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma.
Wilson SJ; Wallin A; Della-Cioppa G; Sandström T; Holgate ST
Am J Respir Crit Care Med; 2001 Sep; 164(6):1047-52. PubMed ID: 11587995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
